Neurology
RSSArticles
-
Pharmacology Watch: Rivaroxaban: Another Warfarin Replacement
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions. -
Sibutramine pulled from market
-
Tiotropium for uncontrolled asthma
-
Incidence and mortality data from WHI
-
FDA actions
-
Pharmacology Watch - Full December 2010 Issue in PDF
-
Neurological Complications of H1N1 Influenza in Children
Children with H1N1 influenza are more likely to have neurologic complications compared to those with non-N1H1 seasonal influenza. -
Is Hyperoxia Harmful After Resuscitation from Cardiac Arrest?
In this study from 120 hospitals in the Project IMPACT database, the presence of hyperoxia (arterial PO2 300 mm Hg or higher) in the first 24 hours after resuscitation from cardiac arrest was associated with a worse in-hospital mortality than either normoxia or hypoxia. -
Type B Aortic Dissection
Indications for surgical or interventional management in acute type B aortic dissection (ABAD) include malperfusion syndromes, progression of dissection, and aneurysm expansion. -
Transcatheter Aortic Valve Implantation for Aortic Stenosis
There is no medical therapy for aortic stenosis (AS), and balloon aortic valvuloplasty (BAV) has sub-optimal long-term results.